Ernst Holler Selected Research

Bacterial DNA

2/2014	Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
8/2011	Antimicrobial peptide response to blood translocation of bacterial DNA in Crohn's disease is affected by NOD2/CARD15 genotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ernst Holler Research Topics

Disease

91	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 09/2002
24	Bronchiolitis Obliterans Syndrome 12/2023 - 02/2006
17	Neoplasms (Cancer) 04/2023 - 02/2007
16	Infections 01/2021 - 03/2002
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2023 - 11/2007
10	Inflammation (Inflammations) 04/2023 - 01/2007
10	Leukemia 11/2019 - 02/2006
7	Crohn Disease (Crohn's Disease) 01/2015 - 08/2004
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2002
6	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 02/2007
5	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2013 - 11/2002
4	Pneumonia (Pneumonitis) 01/2021 - 08/2004
3	Colitis 01/2024 - 01/2018
3	Fever (Fevers) 11/2023 - 03/2002
3	Dysbiosis 11/2023 - 01/2020
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 07/2008
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2016
3	Multiple Myeloma 11/2019 - 02/2007
3	Necrosis 02/2014 - 12/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2010 - 04/2007
3	Hemolytic Anemia 02/2006 - 11/2002
2	Epstein-Barr Virus Infections 01/2023 - 12/2004
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2018
2	Polyneuropathies (Polyneuropathy) 01/2021 - 01/2012
2	Communicable Diseases (Infectious Diseases) 01/2021 - 10/2003
2	Nephritis 09/2020 - 11/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 05/2009
2	Lymphoma (Lymphomas) 01/2016 - 12/2009
2	Hematologic Diseases (Blood Diseases) 01/2016 - 01/2012
2	Sepsis (Septicemia) 10/2013 - 07/2004
2	Neutropenia 01/2011 - 03/2002
2	Thrombocytopenia (Thrombopenia) 01/2007 - 11/2002
2	Lung Injury 03/2005 - 08/2004
2	Thrombosis (Thrombus) 09/2004 - 11/2002
1	Plasmacytoma 01/2024
1	Cytokine Release Syndrome 11/2023
1	Neoplasm Metastasis (Metastasis) 04/2023
1	Viremia 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2006
10	SteroidsIBA 08/2023 - 02/2006
5	CytokinesIBA 08/2005 - 03/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2018
4	GlobulinsIBA 01/2023 - 09/2009
4	Thomsen-Friedenreich antibodiesIBA 01/2023 - 09/2009
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 02/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 03/2002
4	DNA (Deoxyribonucleic Acid)IBA 02/2010 - 08/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 05/2014
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 11/2023 - 12/2016
3	Busulfan (Busulfex)FDA Link 01/2022 - 12/2009
3	fludarabineIBA 01/2020 - 07/2008
3	NucleotidesIBA 08/2015 - 07/2007
3	Methotrexate (Mexate)FDA LinkGeneric 10/2012 - 09/2004
3	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 04/2007
3	Interleukin-6 (Interleukin 6)IBA 06/2010 - 03/2002
3	NF-kappa B (NF-kB)IBA 09/2007 - 08/2004
3	AntigensIBA 02/2007 - 11/2005
2	Melphalan (Alkeran)FDA LinkGeneric 08/2023 - 07/2008
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022 - 06/2010
2	treosulfanIBA 01/2022 - 01/2020
2	Volatile Fatty AcidsIBA 01/2022 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2020 - 11/2002
2	LigandsIBA 01/2018 - 08/2005
2	Antimicrobial PeptidesIBA 01/2017 - 08/2011
2	Hemoglobins (Hemoglobin)IBA 02/2016 - 01/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2015 - 03/2010
2	C-Reactive ProteinIBA 01/2015 - 07/2006
2	Bacterial DNAIBA 02/2014 - 08/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2012 - 09/2009
2	CreatinineIBA 10/2012 - 12/2011
2	ChemokinesIBA 02/2011 - 04/2009
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 06/2010 - 03/2002
2	Interleukin-10 (Interleukin 10)IBA 06/2010 - 12/2004
2	Interferon-gamma (Interferon, gamma)IBA 12/2004 - 11/2002
2	InterleukinsIBA 12/2004 - 09/2002
1	Lipocalin-2IBA 02/2024
1	Interferon Regulatory FactorsIBA 01/2024
1	Basic-Leucine Zipper Transcription FactorsIBA 01/2024
1	melanocortin 5 receptorIBA 01/2024
1	WW Domain-Containing OxidoreductaseIBA 01/2024
1	PaxillinIBA 01/2024
1	Long Noncoding RNAIBA 01/2024
1	Natalizumab (Tysabri)FDA Link 12/2023
1	Immunoglobulin A (IgA)IBA 11/2023
1	heparanaseIBA 04/2023
1	EnzymesIBA 04/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2023
1	Butyrates (Butyrate)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022

Therapy/Procedure

48	Hematopoietic Stem Cell Transplantation 12/2023 - 07/2004
48	Stem Cell Transplantation 11/2023 - 11/2002
24	Therapeutics 11/2023 - 10/2003
19	Cell Transplantation 03/2024 - 07/2008
19	Transplantation 01/2022 - 11/2002
15	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 05/2004
8	Homologous Transplantation 11/2023 - 07/2011
7	Drug Therapy (Chemotherapy) 08/2023 - 03/2002
4	Salvage Therapy 03/2021 - 10/2012
1	Aftercare (After-Treatment) 02/2024